MEDICAL UNIVERSITY OF SOUTH CAROLINA
The Role of Hormonal Dysregulation in Systemic Sclerosis
The Role of Hormonal Dysregulation in Systemic Sclerosis is a funding opportunity from MEDICAL UNIVERSITY OF SOUTH CAROLINA, up to 186469, closing July 31, 2027.
Jul 31, 2027
(365d left)Overview
Although patients with systemic sclerosis (SSc) have increased disability, morbidity, and mortality, no current FDA-approved medications for SSc prevent or reverse fibrosis. Our long-term goal is to understand how E2 influences fibrosis in SSc, which provides the rationale for using medications that inhibit E2…